ArticleFrontiers in immunology2026

Severe renal and pancreatic toxicities associated with ipilimumab and nivolumab combination therapy in non-small cell lung cancer: a pharmacovigilance analysis of the FDA adverse event reporting system.

Jiongrui Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.